Related Experiment Videos

Study of a kindred with hereditary spherocytosis and glyceraldehyde-3-phosphate dehydrogenase deficiency

Blood
|February 1, 1976
PubMed

Insights

Hereditary spherocytosis (HS) patients with glyceraldehyde-3-phosphate dehydrogenase (G3PD) deficiency showed no increased disease severity. However, combined G3PD deficiency and HS red blood cells exhibited signs of metabolic stress.

Area of Science:

  • Hematology
  • Biochemistry
  • Genetics

Background:

  • Hereditary spherocytosis (HS) is a genetic hemolytic anemia.
  • Glyceraldehyde-3-phosphate dehydrogenase (G3PD) deficiency is a rare red blood cell enzyme defect.

Observation:

  • Electrophoresis identified G3PD deficiency in an HS patient.
  • Family studies revealed varying combinations of HS and G3PD deficiency.

Findings:

  • G3PD deficient individuals were likely heterozygous with half-normal enzyme levels.
  • G3PD deficiency alone was asymptomatic.
  • Combined HS and G3PD deficiency did not worsen HS clinical severity.
  • Combined G3PD deficiency and HS increased protein band 4.5, indicating metabolic stress.

Implications:

  • G3PD deficiency does not exacerbate hereditary spherocytosis.
  • Combined HS and G3PD deficiency reveals red blood cell metabolic stress.
  • PAGE SDS is a valuable tool for diagnosing red blood cell enzyme deficiencies and associated membrane changes.

Related Concept Videos